Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Opening up the Chinese drug market

The Chinese pharma market has always been inward-looking, with foreign investors deterred by an unfavorable regulatory climate. However, the government has implemented a raft of reforms with a view to ‘upgrading’ its life sciences sector. Abi Millar explores what this will mean for foreign pharma companies.

Close
Close
Close

Go Top